Infermedica

About Infermedica

Infermedica was founded in 2012 in Wrocław, Poland, and has built one of Europe's most widely deployed medical AI platforms. The company's core product is an AI-powered symptom assessment and clinical triage engine, which powers patient-facing symptom checkers, call centre triage tools, and physician pre-consultation intake workflows for insurers, healthcare systems, and digital health companies. The Infermedica AI uses a proprietary medical knowledge graph—a structured representation of symptoms, conditions, risk factors, and clinical pathways—combined with probabilistic inference to assess patient-reported symptoms and recommend appropriate levels of care (from self-care to emergency). The knowledge graph is built and maintained by a team of physicians and is available in over 30 languages, making Infermedica one of the most linguistically comprehensive medical AI systems globally. Infermedica's API-first architecture enables integration into existing patient-facing applications, insurer member portals, healthcare provider websites, and call centre systems. Customers include Allianz, Bupa, and numerous European national health services. For European healthcare and insurance organisations, Infermedica's Polish incorporation provides a strong EU sovereignty baseline. The company is subject to Polish law, EU law, GDPR, and EU AI Act as corporate law. Data is processed in EU data centres (Poland/Germany). There is no US parent company. Infermedica holds ISO 27001 and ISO 27799 (health informatics information security) certifications, and its AI system is CE-marked as a Class I medical device under EU MDR. For digital health platforms, insurers, and healthcare providers seeking a medically validated, EU-sovereign AI triage and symptom assessment component, Infermedica is one of the strongest available options.